AG
GHDX

Algert Global’s Genomic Health, Inc. GHDX Stock Holding History

Algert Global’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-27,808
Closed -$1.95M – 443
2018
Q3 		$1.95M Sell
27,808
-1,372
-5% -$80.3K 0.42% 87
2018
Q2 		$1.47M Buy
29,180
+460
+2% +$18.3K 0.31% 125
2018
Q1 		$899K Buy
+28,720
New +$953K 0.17% 196
2017
Q1 		– Sell
-20,412
Closed -$600K – 396
2016
Q4 		$600K Sell
20,412
-5,465
-21% -$167K 0.17% 212
2016
Q3 		$748K Buy
+25,877
New +$721K 0.22% 181

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Algert Global's GHDX Position: Q4 2018 in Review

Algert Global sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 27,808 shares — an estimated $1.95M sold.

Algert Global first reported a position in GHDX in Q3 2016 and held it in 5 quarters. The position peaked at $1.95M in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Algert Global reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Algert Global sold 27,808 Genomic Health, Inc. shares in Q4 2018, an estimated $1.95M.
  • Algert Global first reported a position in Genomic Health, Inc. in Q3 2016 and held it in 5 quarters.
  • Algert Global's Genomic Health, Inc. position peaked at $1.95M in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Algert Global's 13F filing for Q4 2018, filed 1 Feb 2019.